ECPC
The European Cancer Patient Coalition (ECPC) is the largest European cancer patients’ umbrella organisation. Established in 2003 with over 450 members in 47 countries, the ECPC is the voice of the European cancer community, uniquely [...]
DTU
The Technical University of Denmark is ranked as one of the foremost technical universities in Europe, DTU is focused on approaching areas of medical biology with a strong technology emphasis. With the vision that new [...]
Maastricht UMC +
The University of Maastricht (UM) and the University Medical Center Maastricht (azM) work together under the umbrella organisation Maastricht UMC+, or Maastricht University Medical Center+. Maastricht UMC+ with a focus on health recovery, health preservation [...]
Eight Patients are now Enrolled in the ImmuoSABR Clinical Trial
Our trial is steadily progressing and we now have eight patients in three centres enrolled in the ImmunoSABR trial .
First Patients Enrolled in ImmuoSABR Clinical Trial
Great news the first patients have been enrolled in the ImmunoSABRclinical Trial at NKI and AZM
METC Approval
METC approval received for the centres in Maastricht, Amsterdam and Nijmegen
Annual ImmunoSABR Meeting 2019
Partners Meeting held in Amsterdam reporting on the progress of the project.
New ImmunoSABR Website Launched
A new website has been designed to provide an overview of the ImmunoSABR project, its progress and information to the general public, patients and potential patients
Presentation – Brussels & Roma
Professor Philippe Lambin - Immunocytokines and Radiation at the Institut Bordet, Brussels. Unconventional immunotherapy and Radiation given in Roma at the yearly national course of radiation Oncology
Presentation – Paris
Professor Philippe Lambin given in Paris at the Immunorad meeting immunocytokines and radiation